Sec Form 4 Filing - Thomas Isiah III @ One World Pharma, Inc. - 2020-12-31

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Thomas Isiah III 2. Issuer Name and Ticker or Trading Symbol One World Pharma, Inc. [ OWPC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO and Vice Chairman (Last) (First) (Middle) 3471 WEST OQUENDO ROAD, SUITE 301 3. Date of Earliest Transaction (MM/DD/YY) 12/31/2020 (Street) LAS VEGAS, NV89118 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to buy) $ 0.55 12/31/2020 D 5,500,000 ( 1 ) 06/03/2030 Common Stock 5,500,000 $ 0 0 D Stock Option (Right to buy) $ 0.13 01/01/2021 A 5,500,000 ( 2 ) 12/31/2030 Common Stock 5,500,000 $ 0 5,500,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Thomas Isiah III 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS, NV89118 X CEO and Vice Chairman Signatures /s/ Isiah L. Thomas III 01/04/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The option vested as to 1,500,000 shares immediately upon issuance (June 3, 2020), as to 1,000,000 shares 120 days following the issuance date of the option (the "Second Vesting Date"), and as to the remaining 3,000,000 shares, quarterly over the three years following the Second Vesting Date. ( 2 )The option vests as to 2,275,000 shares immediately, and as to the remaining 2,750,000 shares, in 11 installments of 250,000 shares each, on the 1st day of each of the next 11 calendar quarters, beginning April 1, 2021.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.